Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Man Loses 6 Stone on Mounjaro, Warns of 'Horrible' Side Effects - Featured image
GLP-1 Medications

Man Loses 6 Stone on Mounjaro, Warns of 'Horrible' Side Effects

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·March 6, 2026·5 min read

On this page

  • Antony Hawman's Journey to Mounjaro
  • What is Mounjaro and How Does It Promote Weight Loss?
  • The Dramatic Results: A Body Transformed
  • The 'Horrible' Side Effects: What Hit Antony Hard
  • How Antony Managed and Overcame Mounjaro Side Effects
  • Who Should Consider Mounjaro? Patient Guidance
  • Safety Considerations and When to Seek Help
  • Key Takeaways: What Antony's Story Means for Mounjaro Users
  • Conclusion: Balancing Risks and Rewards on Mounjaro
  • Common Mounjaro Side Effects According to Eli Lilly

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

A man who shed six stone on Mounjaro shares his dramatic transformation from 123kg, but warns of 'horrible' side effects like chronic vomiting and dehydration no one mentioned. Despite the challenges, he reduced hypertension meds and gained food control. Discover his full story and management strategies.

Share

On this page

  • Antony Hawman's Journey to Mounjaro
  • What is Mounjaro and How Does It Promote Weight Loss?
  • The Dramatic Results: A Body Transformed
  • The 'Horrible' Side Effects: What Hit Antony Hard
  • How Antony Managed and Overcame Mounjaro Side Effects
  • Who Should Consider Mounjaro? Patient Guidance
  • Safety Considerations and When to Seek Help
  • Key Takeaways: What Antony's Story Means for Mounjaro Users
  • Conclusion: Balancing Risks and Rewards on Mounjaro
  • Common Mounjaro Side Effects According to Eli Lilly

Man Loses 6 Stone on Mounjaro, Warns of 'Horrible' Side Effects

Mounjaro side effects can be severe, as one man's inspiring yet cautionary weight loss journey reveals. Antony Hawman, a 48-year-old business owner standing at 6'1", dropped from 123kg (19.5 stone) by nearly 40kg (six stone) using Mounjaro, shrinking from XL/XXL clothes in July 2024 to a medium size with a 30-32 inch waist. Inspired by viral success stories, he started the GLP-1 and GIP receptor drug to combat intense food cravings and emotional eating—but not without brutal hurdles.

Antony Hawman's Journey to Mounjaro

"I decided I wanted to be healthier, which was the main aim," Antony said. At his heaviest, food dominated his life: "I would think about food all the time and I'd use it as a crutch: if I was sad, I'd eat, if I was happy, I'd reward myself with food." Combined with dietary changes and an active lifestyle, Mounjaro's ability to slow digestion and quieten the 'food noise' made it appealing.

What is Mounjaro and How Does It Promote Weight Loss?

Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist approved for type 2 diabetes and weight management. It mimics gut hormones to regulate blood sugar, slow gastric emptying, and reduce appetite signals in the brain. This mechanism addresses the root causes of obesity for many, like Antony's constant cravings, leading to sustainable calorie reduction without constant willpower battles.

Clinical trials, such as SURMOUNT-1, showed average weight loss of 15-20% over 72 weeks, aligning with Antony's rapid six-stone drop. Unlike single GLP-1 drugs like Ozempic (semaglutide), Mounjaro's GIP addition may enhance fat loss and metabolic benefits, though individual responses vary based on starting weight, dose, and lifestyle.

The Dramatic Results: A Body Transformed

Antony's progress was profound. From 123kg and oversized clothing, he now fits mediums and size 30-32 waists. "The best part is I have completely changed my mindset on food. I feel in control instead of it controlling me," he shared. Beyond aesthetics, Mounjaro helped him taper off high-dose hypertension drugs for hereditary hypertension to the lowest level—a major health win.

"As long as you do your research and understand how to nourish your body and take some form of exercise, Mounjaro is an incredible tool, but it's just that, a tool," Antony emphasized. Despite regrets only about not starting sooner, he urges awareness of the downsides.

The 'Horrible' Side Effects: What Hit Antony Hard

A few months in, after moving to 7.5mg in his third month, Antony faced "a pretty miserable weekend of chronic stomach pains, diarrhoea and dehydration." Severe vomiting and diarrhea left him debilitated, highlighting gastrointestinal issues common with incretin mimetics.

Common Mounjaro Side Effects According to Eli Lilly

Manufacturer Eli Lilly lists nausea, diarrhea, vomiting, and stomach pain as the most frequent. These can escalate to dehydration and kidney risks if unmanaged. Antony's experience underscores why dose titration—starting low (e.g., 2.5mg) and increasing gradually—is critical, as rapid escalation amplifies GI distress.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

How Antony Managed and Overcame Mounjaro Side Effects

Turning to TikTok chat rooms, Antony heeded advice from a woman in Texas: drop to 5mg, add electrolytes, and take a probiotic. He adopted Symprove daily, eliminating symptoms entirely. This DIY approach stabilized him, allowing continued use.

For patients, strategies include:

  • Hydration and electrolytes: Prevent dehydration with oral rehydration solutions.
  • Probiotics: Symprove or similar to restore gut balance disrupted by slowed digestion.
  • Dose adjustment: Consult doctors before changes; apps like Shotlee can track symptoms, doses, and side effects for better doctor discussions.
  • Anti-nausea aids: Ginger, small meals, or prescribed meds.

Monitoring via tools like Shotlee helps log vomiting episodes or stool changes, spotting patterns early.

Who Should Consider Mounjaro? Patient Guidance

Mounjaro suits adults with BMI ≥30 (or ≥27 with comorbidities) unresponsive to diet/exercise. Antony's profile—obese with hypertension and cravings—fits ideally. Discuss with providers if you have GI history, as risks rise.

Compared to Wegovy (semaglutide up to 2.4mg), Mounjaro often yields more weight loss but similar GI sides. Always pair with nutrition (high-protein, fiber-rich) and exercise for best outcomes, as Antony did.

Safety Considerations and When to Seek Help

While effective, watch for red flags: persistent vomiting (>24 hours), severe pain, or signs of pancreatitis/kidney issues. Eli Lilly advises prompt medical attention for dehydration. Long-term data shows most sides wane, but gallbladder or thyroid risks exist (rare).

Antony's story shows persistence pays, but never ignore symptoms—professional oversight is key.

Key Takeaways: What Antony's Story Means for Mounjaro Users

  • Mounjaro can deliver six-stone losses and mindset shifts, reducing meds like hypertension drugs.
  • Severe GI side effects like vomiting/diarrhea are real but manageable with dose tweaks, electrolytes, and probiotics like Symprove.
  • Research communities (safely) and track via apps; combine with lifestyle for sustained success.
  • Antony doesn't regret it: "I wished I'd found the drug sooner."

Conclusion: Balancing Risks and Rewards on Mounjaro

Antony Hawman's tale captures Mounjaro's power for metabolic health—slashing weight, taming cravings, and easing comorbidities—tempered by 'horrible' side effects demanding vigilance. For those battling obesity, it's a tool worth exploring with a doctor, armed with strategies like his. Prioritize hydration, gradual dosing, and monitoring to turn potential misery into transformation.

Source Information

Originally published by LADbible.Read the original article →

Read next

Keep exploring

More on Mounjaro

Articles covering Mounjaro dosing, side effects, and clinical updates.

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
Health & Wellness

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks

The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.

8 min read
Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
Health & Wellness

Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure

GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.

8 min read
Wegovy Pill Arrives in the UK: A New Era for Weight Management?
Health & Wellness

Wegovy Pill Arrives in the UK: A New Era for Weight Management?

The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.

6 min read

Same topic: Mounjaro

All Mounjaro articles →
Mounjaro (Tirzepatide) PBS Listing Fails: Impact on Australian Patients
Pharmaceutical Policy & Access

Mounjaro (Tirzepatide) PBS Listing Fails: Impact on Australian Patients

Eli Lilly Australia has announced that Mounjaro (tirzepatide) will not be listed on the Pharmaceutical Benefits Scheme (PBS) for Type 2 Diabetes, citing unsustainable funding conditions. This decision highlights ongoing challenges in accessing modern GLP-1 and GIP therapies.

6 min read
Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business
GLP-1 Medications

Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business

Marc McKee dropped nine stone with Mounjaro, transforming his health but leaving him with loose skin that inspired a new business. ElastiK Skin targets GLP-1 weight loss side effects using peptides, hyaluronic acid, and LED therapy. Early users report better hydration and elasticity with consistent use.

5 min read
Mounjaro Face Effect: Causes and Prevention Tips
GLP-1 Medications

Mounjaro Face Effect: Causes and Prevention Tips

The hype around Mounjaro's weight loss results is real, but so is 'Mounjaro face'—sharper yet tired-looking facial changes from rapid fat loss. Dermatologists and surgeons report more patients with hollowed cheeks and sagging skin seeking help. Experts reveal why it occurs and essential prevention strategies focusing on nutrition and skincare.

6 min read

More in GLP-1 Medications

Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise
Medical News

Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise

Eli Lilly has released pivotal Phase 3 trial data for retatrutide, a triple agonist showing up to 28% body weight reduction and significant improvements in diabetes and sleep apnea.

7 min read
Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39
Health & Wellness

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39

The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.

7 min read
Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym
Medical Insights

Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym

For individuals struggling with difficult-to-control type 2 diabetes and weight management, even powerful GLP-1 medications might not be enough. New research highlights the significant role of hypercortisolism and the promising potential of Korlym in optimizing treatment outcomes.

6 min read
Share this article
  1. Home
  2. Blog
  3. Man Loses 6 Stone on Mounjaro, Warns of 'Horrible' Side Effects
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community